Les publications

338 publications
Année de publication :
Réseaux :

Abemaciclib: FDA-Approved Small Molecule for Metastatic Breast Cancer.

Abemaciclib (Verzerio®) is a cell cycle inhibitor of both CDK4 and CDK6. In 2017, abemaciclib was approved by the Food and Drug Administration (FDA) and, in 2018 by the European Medicines Agency (EMA) for the treatment of postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative…

  • Ref: Open J. Med. Chem. 2020, 10, 128-138.
  • Auteurs : Voli LA, Mamyrbékova JA, Bazureau JP.
Lire la publication

Mitochondria transfer from TASC to primary Glioblastoma cells.

The tumor microenvironment (TME) controls many aspects of cancer development but little is known about its effect in Glioblastoma (GBM), the main brain tumor in adults.

  • Ref: Biochem Biophys Res Commun. 2020 Sep 14:S0006-291X(20)31699-5.
  • Auteurs : Salaud C, Alvarez-Arenas A, Geraldo F, Belmonte-Beitia J, Calvo GF, Gratas C, Pecqueur C, Garnier D, Pérez-Garcià V, Vallette FM, Oliver L.
Lire la publication